Structural Studies of Matrix Metalloproteinase by X-Ray Diffraction. 2017

Elena Decaneto, and Wolfgang Lubitz, and Hideaki Ogata
Max Planck Institute for Chemical Energy Conversion, Stiftstrasse 34-36, 45470, Mülheim an der Ruhr, Germany.

Matrix Metalloproteinases (MMPs) are a family of proteolytic enzymes whose endopeptidase activity is dependent on the presence of specific metal ions. MT1-MMP (or MMP-14), which has been implicated in tumor progression and cellular invasion, contains a membrane-spanning region located C-terminal to a hemopexin-like domain and an N-terminal catalytic domain. We recombinantly expressed the catalytic domain of human MT1-MMP in E. coli and purified it from inclusion bodies using a refolding protocol that yielded significant quantities of active protein. Crystals of MT1-MMP were obtained using the vapour diffusion method. Here, we describe the protocols used for crystallization and the data analysis together with the resulting diffraction pattern.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D015202 Protein Engineering Procedures by which protein structure and function are changed or created in vitro by altering existing or synthesizing new structural genes that direct the synthesis of proteins with sought-after properties. Such procedures may include the design of MOLECULAR MODELS of proteins using COMPUTER GRAPHICS or other molecular modeling techniques; site-specific mutagenesis (MUTAGENESIS, SITE-SPECIFIC) of existing genes; and DIRECTED MOLECULAR EVOLUTION techniques to create new genes. Genetic Engineering of Proteins,Genetic Engineering, Protein,Proteins, Genetic Engineering,Engineering, Protein,Engineering, Protein Genetic,Protein Genetic Engineering
D053511 Matrix Metalloproteinase 14 A transmembrane domain-containing matrix metalloproteinase. It is synthesized as an inactive zymogen that is activated by the action of PROPROTEIN CONVERTASES such as FURIN. Matrix metalloproteinase 14 plays a direct role in the cleavage of proteins in the pericellular environment. In addition, it can function indirectly by enzymatically activating the proprotein form of MATRIX METALLOPROTEINASE 15. MMP-14 Metalloproteinase,MMP-X1 Protein,MMP14 Metalloproteinase,MT-MMP-1,MT1-MMP,MT1-Matrix Metalloproteinase,Membrane-Type 1 Matrix Metalloproteinase,Membrane-Type Matrix Metalloproteinase 1,MMP 14 Metalloproteinase,MMP X1 Protein,MT1 Matrix Metalloproteinase,Membrane Type 1 Matrix Metalloproteinase,Membrane Type Matrix Metalloproteinase 1,Metalloproteinase 14, Matrix,Metalloproteinase, MMP-14,Metalloproteinase, MMP14,Metalloproteinase, MT1-Matrix
D058849 Protein Refolding Conformational transitions of a protein from unfolded states (after PROTEIN UNFOLDING) to a more folded state. Refolding, Protein
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies
D020134 Catalytic Domain The region of an enzyme that interacts with its substrate to cause the enzymatic reaction. Active Site,Catalytic Core,Catalytic Region,Catalytic Site,Catalytic Subunit,Reactive Site,Active Sites,Catalytic Cores,Catalytic Domains,Catalytic Regions,Catalytic Sites,Catalytic Subunits,Core, Catalytic,Cores, Catalytic,Domain, Catalytic,Domains, Catalytic,Reactive Sites,Region, Catalytic,Regions, Catalytic,Site, Active,Site, Catalytic,Site, Reactive,Sites, Active,Sites, Catalytic,Sites, Reactive,Subunit, Catalytic,Subunits, Catalytic

Related Publications

Elena Decaneto, and Wolfgang Lubitz, and Hideaki Ogata
September 1994, Physical review. B, Condensed matter,
Elena Decaneto, and Wolfgang Lubitz, and Hideaki Ogata
April 1991, Biophysical journal,
Elena Decaneto, and Wolfgang Lubitz, and Hideaki Ogata
March 1972, Biochemistry,
Elena Decaneto, and Wolfgang Lubitz, and Hideaki Ogata
January 1980, Progress in clinical and biological research,
Elena Decaneto, and Wolfgang Lubitz, and Hideaki Ogata
September 2004, Acta crystallographica. Section A, Foundations of crystallography,
Elena Decaneto, and Wolfgang Lubitz, and Hideaki Ogata
November 1979, Journal of molecular biology,
Elena Decaneto, and Wolfgang Lubitz, and Hideaki Ogata
January 2012, Ayu,
Elena Decaneto, and Wolfgang Lubitz, and Hideaki Ogata
January 1970, Annual review of biochemistry,
Elena Decaneto, and Wolfgang Lubitz, and Hideaki Ogata
January 1987, Methods in enzymology,
Elena Decaneto, and Wolfgang Lubitz, and Hideaki Ogata
January 1981, Annual review of physiology,
Copied contents to your clipboard!